These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16491956)

  • 1. Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines.
    Grivicich I; Regner A; da Rocha AB; Grass LB; Alves PA; Kayser GB; Schwartsmann G; Henriques JA
    Oncol Res; 2005; 15(7-8):385-92. PubMed ID: 16491956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells.
    Grivicich I; Regner A; da Rocha AB; Kayser GB; Schunemann DP; Grass LB; Alves PA; Henriques JA; Schwartsmann G
    Chemotherapy; 2005 May; 51(2-3):93-102. PubMed ID: 15886469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines.
    Mans DR; Grivicich I; Peters GJ; Schwartsmann G
    Eur J Cancer; 1999 Dec; 35(13):1851-61. PubMed ID: 10674003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
    Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
    Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells.
    Ocker M; Alajati A; Ganslmayer M; Zopf S; Lüders M; Neureiter D; Hahn EG; Schuppan D; Herold C
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):385-94. PubMed ID: 15754201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line.
    Guichard S; Hennebelle I; Bugat R; Canal P
    Biochem Pharmacol; 1998 Mar; 55(5):667-76. PubMed ID: 9515577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells.
    Bunpo P; Kataoka K; Arimochi H; Nakayama H; Kuwahara T; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2005 Feb; 52(1-2):65-73. PubMed ID: 15751275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes.
    Bergmann-Leitner ES; Abrams SI
    Cancer Immunol Immunother; 2001 Nov; 50(9):445-55. PubMed ID: 11761438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines.
    Harris SM; Mistry P; Freathy C; Brown JL; Charlton PA
    Br J Cancer; 2005 Feb; 92(4):722-8. PubMed ID: 15700035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.
    Allen WL; Stevenson L; Coyle VM; Jithesh PV; Proutski I; Carson G; Gordon MA; Lenz HJ; Van Schaeybroeck S; Longley DB; Johnston PG
    Mol Cancer Ther; 2012 Jan; 11(1):119-31. PubMed ID: 22027693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
    Nakajima TE; Yasunaga M; Kano Y; Koizumi F; Kato K; Hamaguchi T; Yamada Y; Shirao K; Shimada Y; Matsumura Y
    Int J Cancer; 2008 May; 122(9):2148-53. PubMed ID: 18196580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells.
    Uchida H; Shinoura N; Kitayama J; Watanabe T; Nagawa H; Hamada H
    J Gene Med; 2003 Apr; 5(4):287-99. PubMed ID: 12692863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
    Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
    Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.
    Chan JY; Phoo MS; Clement MV; Pervaiz S; Lee SC
    Cancer Biol Ther; 2008 Aug; 7(8):1305-12. PubMed ID: 18497562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner.
    Higby KJ; Bischak MM; Campbell CA; Anderson RG; Broskin SA; Foltz LE; Koper JA; Nickle AC; Resendes KK
    Apoptosis; 2017 Mar; 22(3):393-405. PubMed ID: 28000054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.
    Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Yanagi H; Kusunoki M
    J Gastroenterol; 2006 Dec; 41(12):1149-57. PubMed ID: 17287894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
    Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
    Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
    Fukushima M; Sakamoto K; Ohshimo H; Nakagawa F; Taguchi T
    Oncol Rep; 2010 Oct; 24(4):835-42. PubMed ID: 20811661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.